OmniLife

Lexington, United States Founded: 2016 • Age: 10 yrs
Platform automates clinical workflows for transplant and healthcare management.

About OmniLife

OmniLife is a Healthcare company based in Lexington (United States) founded in 2016. It operates as a platform automates clinical workflows for transplant and healthcare management. It operates on a SaaS and B2B model. OmniLife offers products and services including FlowHawk, OrganFlow, and PatientFlow. Its focus areas include Medical Technology, Clinical Workflow, Organ Transplant Management and Oncology and Cardiology. Its legal entity is HealthTech Solutions Inc. Its competitors include Vocera, OptimizeRx, Spok, HealthCrowd and Paubox and 2 more; 4 of its 7 listed competitors have raised funding.

Company details

OmniLife Health provides digital tools to simplify complex clinical workflows in healthcare, focusing on organ transplant centers, oncology, and cardiology. It connects care teams, standardizes processes, and improves outcomes through platforms like FlowHawk. Based in Beaverton, USA, it serves hospitals, health systems, and transplant vendors by enhancing collaboration and reducing staffing challenges. The company emphasizes secure communication and process optimization for better patient care.

  • Headquarters Lexington, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website getomnilife.com
  • Social LinkedIn X Facebook
  • Legal Name Healthtech Solutions Inc
Key Metrics

Products & Services of OmniLife

OmniLife offers a comprehensive portfolio of products and services, including FlowHawk, OrganFlow, and PatientFlow.

FlowHawk
Workflow Automation

Platform simplifies clinical workflows for care teams.

OrganFlow
Organ Management

Tool handles organ intake and waitlist processes.

PatientFlow
Patient Management

System manages patient referrals and care journeys.

Funding Insights of OmniLife

  • Total Rounds 2
  • Investors Count 2

All 2 funding rounds of OmniLife with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2022–Grant––
Jul 2021–Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in OmniLife

OmniLife has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include National Institute of Diabetes and Digestive and Kidney Diseases and KY Innovation.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Support for entrepreneurs and startups is provided in Kentucky.
–kyinnovation.comFrankfort, United States
Research and health information on diabetes and kidney diseases are provided by NIDDK.
1950niddk.nih.govUnited States
Premium access

Investor details for OmniLife

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of OmniLife

16 people are tracked at OmniLife (1 in leadership, 14 in board & advisors, 1 in team).

NameRoleGroup
Cynthia Edge
Vice President of OperationsLeadership
Robert Emery
AdvisorBoard & advisors
Kevin Smith
AdvisorBoard & advisors
Alan Reed
AdvisorBoard & advisors
Angie Korsun
AdvisorBoard & advisors
Angela Lorts
AdvisorBoard & advisors
Karl Welke
AdvisorBoard & advisors
George Mazariegos
AdvisorBoard & advisors
Michael Volk
AdvisorBoard & advisors
David Peng
AdvisorBoard & advisors
Dana Perry
AdvisorBoard & advisors
Tommy Mulligan
AdvisorBoard & advisors
John Bucavalas
AdvisorBoard & advisors
Frank L. Poggio
AdvisorBoard & advisors
Jake Sorg
AdvisorBoard & advisors
Shayda Nazifpour
Regional Sales ManagerTeam
Premium access

Complete people profiles for OmniLife

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of OmniLife

3 dated milestones of OmniLife across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded OmniLife is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant,.

Competitors of OmniLife

OmniLife has 7 listed competitors in our database, 4 of them funded. They include Vocera, OptimizeRx, Spok, HealthCrowd and Paubox, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
vocera.com2000San Jose, United States$47.9M145
Cloud-based messaging and workflow solutions are delivered for healthcare providers.
optimizerx.com2006Rochester, United States–94
Cloud-based platform enables hospital point-of-care communication management.
spok.com1984Fairfax, United States–376
Secure messaging and clinical alerting solutions are provided for healthcare.
healthcrowd.com2011San Mateo, United States$4.12M47
AI and cloud-based platform is provided for healthcare provider communications.
paubox.com2014San Francisco, United States$14.03M43
Cloud-based email encryption solutions are provided for healthcare providers.
telmediq.com2012Mackenzie, Canada$127,511–
HIPAA-compliant secure messaging is delivered for healthcare communications.
amcomsoftware.com1984Eden Prairie, United States––
Healthcare communication software and hardware are supplied to hospitals.
Premium access

Detailed competitors of OmniLife

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Transplant Medicine

10 companies that operate in the same segment as OmniLife (Transplant Medicine), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medical solutions for transplant patients are developed and provided.
1998Brisbane, California, United StatesUSD 138.21 MUSD 379.81 M650
Developer of organ transplantation technology
1998Andover, Massachusetts, United StatesUSD 265.55 MUSD 605.49 M728
Warm storage and transport systems for harvested organs are provided.
2008Oxford, Oxfordshire, United KingdomUSD 45.42 MUSD 1.36 M14
Human tissue-based products are developed for vascular disease applications.
2004Morrisville, United StatesUSD 424.76 MUSD 2.04 M220
Next-generation medicines for CNS and immunological disorders are developed.
2007New York, New York, United StatesUSD 4.45 MUSD 13.11 M81
Breakthrough therapies are developed for blood diseases and infections.
2014Buffalo, New York, United StatesUSD 1 M–22
Personalized skin tissue therapy is developed by CUTISS for surgeries.
2017Zurich, SwitzerlandUSD 94.37 M––
Game currency trading services are provided by Magenta Piman.
2016Cambridge, Massachusetts, United StatesUSD 150.5 M–75
T regulatory cell therapies are developed for immunological diseases.
2019London, England, United KingdomUSD 344.25 M––
Therapeutics for transplantation in autoimmune and neurodegenerative diseases are developed.
2004Irvine, California, United StatesUSD 1.89 M–31
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Omnilife

Premium access

Complete news archive for OmniLife

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about OmniLife

OmniLife was founded in 2016 and raised its 1st funding round 5 years after it was founded.

OmniLife is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.

Annual revenue of OmniLife is $681K as on Dec 31, 2020.

OmniLife Health provides digital tools to simplify complex clinical workflows in healthcare, focusing on organ transplant centers, oncology, and cardiology. It connects care teams, standardizes processes, and improves outcomes through platforms like FlowHawk. Based in Beaverton, USA, it serves hospitals, health systems, and transplant vendors by enhancing collaboration and reducing staffing challenges. The company emphasizes secure communication and process optimization for better patient care.

OmniLife's top competitors include Vocera, OptimizeRx and HealthCrowd.

OmniLife offers FlowHawk, OrganFlow, and PatientFlow.

OmniLife has 2 investors. Key investors include National Institute of Diabetes and Digestive and Kidney Diseases, and KY Innovation.

OmniLife operates through Healthtech Solutions Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available